LPL Financial’s Trillium Therapeutics Inc. TRIL Stock Holding History

LPL Financial’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-191,328	Closed	-$3.36M	–	4532
2021 Q3	$3.36M	Sell	191,328 -53,145	-22%	-$621K	﹤0.01%	1663
2021 Q2	$2.37M	Buy	244,473 +6,003	+3%	+$56.5K	﹤0.01%	1832
2021 Q1	$2.56M	Buy	238,470 +29,665	+14%	+$367K	﹤0.01%	1661
2020 Q4	$3.07M	Buy	208,805 +16,715	+9%	+$241K	﹤0.01%	1401
2020 Q3	$2.73M	Buy	192,090 +34,020	+22%	+$339K	﹤0.01%	1292
2020 Q2	$1.28M	Buy	158,070 +115,620	+272%	+$715K	﹤0.01%	1654
2020 Q1	$171K	Buy	42,450 +29,825	+236%	+$113K	﹤0.01%	2866
2019 Q4	$13K	Buy	+12,625	New	+$4.83K	﹤0.01%	3327

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

LPL Financial's TRIL Position: Q4 2021 in Review

LPL Financial sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 191,328 shares — an estimated $3.36M sold.

LPL Financial first reported a position in TRIL in Q4 2019 and held it in 8 quarters. The position peaked at $3.36M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

LPL Financial reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
LPL Financial sold 191,328 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $3.36M.
LPL Financial first reported a position in Trillium Therapeutics Inc. in Q4 2019 and held it in 8 quarters.
LPL Financial's Trillium Therapeutics Inc. position peaked at $3.36M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on LPL Financial's 13F filing for Q4 2021, filed 14 Feb 2022.